Cargando…
Phase II Clinical Trial of Pegylated Liposomal Doxorubicin (JNS002) in Japanese Patients with Müllerian Carcinoma (Epithelial Ovarian Carcinoma, Primary Carcinoma of Fallopian Tube, Peritoneal Carcinoma) Having a Therapeutic History of Platinum-based Chemotherapy: A Phase II Study of the Japanese Gynecologic Oncology Group
OBJECTIVE: This study was conducted to evaluate the efficacy and safety of pegylated liposomal doxorubicin (PLD) in Japanese patients with Müllerian carcinoma having a therapeutic history of platinum-based chemotherapy. METHODS: Patients who were diagnosed with Müllerian carcinoma (epithelial ovaria...
Autores principales: | Katsumata, Noriyuki, Fujiwara, Yasuhiro, Kamura, Toshiharu, Nakanishi, Toru, Hatae, Masayuki, Aoki, Daisuke, Tanaka, Kenichi, Tsuda, Hiroshi, Kamiura, Shoji, Takehara, Kazuhiro, Sugiyama, Toru, Kigawa, Junzo, Fujiwara, Keiichi, Ochiai, Kazunori, Ishida, Ryo, Inagaki, Mitsuo, Noda, Kiichiro |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2572298/ https://www.ncbi.nlm.nih.gov/pubmed/18927230 http://dx.doi.org/10.1093/jjco/hyn101 |
Ejemplares similares
-
An open-label, randomized, phase II trial evaluating the efficacy and safety of standard of care with or without bevacizumab in platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer patients previously treated with bevacizumab for front-line or platinum-sensitive ovarian cancer: rationale, design, and methods of the Japanese Gynecologic Oncology Group study JGOG3023
por: Shoji, Tadahiro, et al.
Publicado: (2018) -
Comparison of the outcome between cervical adenocarcinoma and squamous cell carcinoma patients with adjuvant radiotherapy following radical surgery: SGSG/TGCU Intergroup Surveillance
por: SHIMADA, MUNEAKI, et al.
Publicado: (2013) -
Phase II study of S-1, an oral fluoropyrimidine, in patients with advanced or recurrent cervical cancer
por: Katsumata, N., et al.
Publicado: (2011) -
Phase II trial of docetaxel in advanced or metastatic endometrial cancer: a Japanese Cooperative Study
por: Katsumata, N, et al.
Publicado: (2005) -
Cabozantinib in advanced renal cell carcinoma: A phase II, open‐label, single‐arm study of Japanese patients
por: Tomita, Yoshihiko, et al.
Publicado: (2020)